Viatris (MIL:1VTRS) COGS-to-Revenue : 0.59 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Viatris COGS-to-Revenue?

Viatris's Cost of Goods Sold for the three months ended in Mar. 2024 was €1,987 Mil. Its Revenue for the three months ended in Mar. 2024 was €3,370 Mil.

Viatris's COGS to Revenue for the three months ended in Mar. 2024 was 0.59.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Viatris's Gross Margin % for the three months ended in Mar. 2024 was 41.05%.

Viatris COGS-to-Revenue Historical Data

The historical data trend for Viatris's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viatris COGS-to-Revenue Chart

Viatris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.66

0.68

0.69

0.60

0.58

Viatris Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.59	0.59	0.57	0.58	0.59

Viatris COGS-to-Revenue Calculation

Viatris's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	8242.271	/	14146.467
	=	0.58

Viatris's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1986.648	/	3370.328
	=	0.59

Viatris (MIL:1VTRS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Viatris's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1986.648 / 3370.328
	=	41.05 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Viatris COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Viatris's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Viatris (MIL:1VTRS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viatris Inc (MIL:1VTRS) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

VTRS:USA MYL:Mexico 0A5V:UK VIA:Germany MYL:Austria

Address

1000 Mylan Boulevard, Canonsburg, PA, USA, 15317

Website

https://www.viatris.com

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Viatris (MIL:1VTRS) Headlines

No Headlines